Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;11(4):311-317.
doi: 10.1212/CPJ.0000000000000970.

Achieving Life Milestones in Duchenne/Becker Muscular Dystrophy: A Retrospective Analysis

Affiliations

Achieving Life Milestones in Duchenne/Becker Muscular Dystrophy: A Retrospective Analysis

Andrew Donaldson et al. Neurol Clin Pract. 2021 Aug.

Abstract

Objective: To understand the milestones achieved in the transition from childhood to adulthood for patients with Duchenne and Becker muscular dystrophies (DMD/BMD).

Methods: We performed a retrospective chart review on patients aged 15 years or older with a clinical diagnosis of DMD/BMD who received care from January 1, 2008, to January 1, 2018 at the University of Kansas Medical Center and the University of Rochester Medical Center. Participants were identified using local Muscular Dystrophy Asssociation-funded clinic lists, neuromuscular research databases, and electronic medical record review. Data were abstracted using a uniform template on education, employment, community resources, relationships, and end-of-life discussions and is presented as mean, median, or frequency with associated 95% confidence interval (CI).

Results: A total of 109 patients were identified: patients ranged in age from 15 to 56 years with a median of 24, and covered a 5-state region and Ontario, Canada. Seventy-eight percent of patients had DMD and were, on average, 8.5 years younger than patients with BMD. Over half (56.9%, 95% CI 47.6-66.2) were high school graduates or beyond. Sixteen percent did not have their highest level of education documented. Only 20.0% had an occupation (95% CI 12.7-27.7), most frequently in education and administrative support (34%). The majority were still living with parents (80.7%, 95% CI 73.3-88.1). A minority reported having end-of-life discussions (17.4%, 95% CI 10.3-24.6).

Conclusions: Psychosocial elements reflecting the transition to adulthood are inconsistently reported in clinical documentation. A prospective study will further elucidate this transition.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Highest Level of Education Achieved
This figure represents the highest level of education achieved by the patient cohort. Patients were classified as having some high school if we could identify that the patient had been enrolled in high school, but there was nothing in the chart to indicate they had graduated. Similarly, patients were classified as having some college or some graduate school if they had enrolled in coursework at that educational level, and there was no mention of their graduation in the chart.
Figure 2
Figure 2. Job Fields of Patients With DMD/BMD
(A) Over half of the DMD cohort was employed in either educational fields or in office work. (B) Unlike DMD, patients with BMD were also employed in construction or manufacturing. BMD = Becker muscular dystrophy; DMD = Duchenne muscular dystrophy.
Figure 3
Figure 3. Social Relationships and Advance Planning
(A) Living situation. Eighty-one percent of this patient population remained living with their parents at the time of this study (95% CI 73.3–88.1). Only 10% of patients had achieved living independently (95% CI 4.4–15.7). Of note, 1 patient is homeless. (B) Relationship status. Ninety percent of patients with DMD or BMD are single (95% CI 84.2–95.6), with a small minority currently married or divorced. (C) End-of-life care discussions. Only 17% of patients had a documented advance planning discussion in their charts (95% CI 10.3–24.6). BMD = Becker muscular dystrophy; CI = confidence interval; DMD = Duchenne muscular dystrophy.

References

    1. Birnkrant DJ, Bushby K, Bann CM, et al. . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17:251–267. - PMC - PubMed
    1. Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2014;24:482–491. - PubMed
    1. McDonald CM, Henricson EK, Abresch RT, et al. . Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 2018;391:451–461. - PubMed
    1. Darras BT, Urion DK, Ghosh P. Dystrophinopathies. In: GeneReviews [online]. Seattle: University of Washington, Seattle; 2000. Available at: ncbi.nlm.nih.gov/books/NBK1119/. Accessed February 22, 2018.
    1. Centers for Disease Control and Prevention (CDC). Prevalence of Duchenne/Becker muscular dystrophy among males aged 5–24 years—four states, 2007. MMWR Morb Mortal Wkly Rep 2009;58:1119–1122. - PubMed